Phase 3 Trial Results of Stelara for Crohn’s Disease Indicate Promising Results
News
Janssen Pharmaceuticals’ drug candidate Stelara (ustekinumab) demonstrated positive therapeutic effects in a recent Phase 3 clinical trial, inducing clinical response and remission in adult patients with moderate to severe Crohn’s ... Read more